Usage Information

Heparin-binding EGF-like growth factor contributes to reduced glomerular filtration rate during glomerulonephritis in rats
Lili Feng, Gabriela E. Garcia, Young Yang, Yiyang Xia, Francis B. Gabbai, Orjan W. Peterson, Judith A. Abraham, Roland C. Blantz, Curtis B. Wilson
Lili Feng, Gabriela E. Garcia, Young Yang, Yiyang Xia, Francis B. Gabbai, Orjan W. Peterson, Judith A. Abraham, Roland C. Blantz, Curtis B. Wilson
View: Text | PDF
Article

Heparin-binding EGF-like growth factor contributes to reduced glomerular filtration rate during glomerulonephritis in rats

Abstract

Heparin-binding epidermal growth factor–like growth factor (HB-EGF), a member of the epidermal growth factor (EGF) family, is expressed during inflammatory and pathological conditions. We have cloned the rat HB-EGF and followed the expression of HB-EGF in rat kidneys treated with anti– glomerular basement membrane (anti–GBM) antibody (Ab) to induce glomerulonephritis (GN). We observed glomerular HB-EGF mRNA and protein within 30 minutes of Ab administration and showed by in situ hybridization that glomerular HB-EGF mRNA expression was predominantly in mesangial and epithelial cells. Expression of HB-EGF correlated with the onset of decreased renal function in this model. To test the direct effect of HB-EGF on renal function, we infused the renal cortex with active rHB-EGF, prepared from transfected Drosophila melanogaster cells. This treatment induced a significant decrease in single nephron GFR (SNGFR), single nephron plasma flow, and glomerular ultrafiltration coefficient and an increase in the glomerular capillary hydrostatic pressure gradient. In addition, anti–HB-EGF Ab administered just before anti-GBM Ab blocked the fall in SNGFR and GFR at 90 minutes without any change in the glomerular histologic response. These studies suggest that HB-EGF expressed early in the anti-GBM Ab GN model contributes to the observed acute glomerular hemodynamic alterations.

Authors

Lili Feng, Gabriela E. Garcia, Young Yang, Yiyang Xia, Francis B. Gabbai, Orjan W. Peterson, Judith A. Abraham, Roland C. Blantz, Curtis B. Wilson

×

Usage data is cumulative from October 2025 through October 2026.

Usage JCI PMC
Text version 726 34
PDF 222 10
Figure 671 0
Table 181 0
Citation downloads 178 0
Totals 1,978 44
Total Views 2,022
(Click and drag on plot area to zoom in. Click legend items above to toggle)

Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.

Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.

Advertisement